Bill

Bill > A973


NJ A973

NJ A973
Expands definition of personal data to include use of reproductive health care services and prohibits collection of reproductive health care prescription drugs from Prescription Monitoring Program.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill expands the provisions of P.L.2023, c.266, which requires notification to consumers of the collection and use of personal data by certain entities, and requires those entities to provide consumers with the means of opting out of targeted advertising, location tracking, and customer profiling. Under the bill, the definitions of "personal data" and "sensitive data" are amended to include data concerning a person's use of or attempt to use reproductive health care services. Additionally, under the bill, entities that control or process personal data are prohibited from disclosing such data to the extent that disclosure would be in furtherance of imposing civil or criminal liability upon a person or entity for the provision, receipt, or seeking of, or inquiring or responding to an inquiry about reproductive health care services that are legal in this State but may not be legal outside this State. This bill also amends P.L.2007, c.244, concerning the State's Prescription Monitoring Program, to prohibit the expansion of the program to prescription drugs used for sterilization, contraception, termination of pregnancy, in-vitro fertilization, or any reproductive health care services.

AI Summary

This bill expands the definition of "personal data" and "sensitive data" to include information about a person's use of or attempt to use reproductive health care services, and prohibits entities that control or process personal data from disclosing such information if it could lead to legal liability for obtaining or providing legal reproductive health care services in the state. Additionally, the bill amends the state's Prescription Monitoring Program, which tracks prescription drug use, to prevent its expansion to include prescription drugs used for sterilization, contraception, abortion, in-vitro fertilization, or any other reproductive health care services.

Sponsors (2)

Last Action

Introduced, Referred to Assembly Health Infrastructure Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...